Developer docs
API playgroundTry for free, no card

Search company profiles

Aluna

Full company profile

uuid0035dgd

Namestring
Aluna
Legal namestring
Huma Therapeutics Inc
Websiteurl
alunacare.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Aluna is a digital health company that develops and sells a portable, FDA-cleared digital spirometer and companion mobile application for the daily monitoring of lung function by patients with asthma and cystic fibrosis. Founded in 2016 by Charvi Shetty (CEO) and Inderjit Jutla (CSO) out of UC Berkeley, the company combines a differential pressure sensor with a proprietary machine learning algorithm to deliver hospital-grade accuracy — validated against the nSpire Koko desktop reference system — in a Bluetooth-connected, USB-rechargeable consumer device with a removable mouthpiece. The ML pipeline performs 'adequate effort' quality detection, BTPS environmental corrections using phone-sensor inputs (barometer, accelerometer, internal temperature), and automated at-risk patient flagging. Aluna sells the device direct-to-consumer through alunacare.com (US-only), operates a web-based Provider Dashboard for remote patient monitoring with CPT-code billing workflows, and offers a Clinical Trials Platform for CROs and academic institutions. Revenue is generated through one-time hardware sales and recurring subscription/app services processed via Stripe and Apple App Store. The company was acquired by Huma Therapeutics in May 2025 and now operates as a subsidiary of Huma Therapeutics Inc.

Short descriptiontext

Aluna builds an FDA-cleared portable digital spirometer and companion mobile app that enable daily at-home lung function monitoring for asthma and cystic fibrosis patients, serving also healthcare providers and clinical trial sponsors. Acquired by Huma Therapeutics in May 2025.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital spirometry device, respiratory health monitoring, remote patient monitoring, lung function tracking, connected health platform
Industry4 codes
PRIMARYHLAHAGAH
Pulmonary Function Testing (PFT) & Spirometry Equipment
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHAGAI
Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Digital Respiratory Health Devices
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Hardware Device Sales
TypeHardware Sales
Description

Aluna sells its digital spirometer device directly to consumers and healthcare providers. The device is available for purchase through the website and connects to the companion app via Bluetooth.

alunacare.com
2Subscription Services
TypeSubscription Recurring
Description

Aluna offers subscription billing for app services. Credit card payment processing is handled through Stripe and Apple App Store. Subscription includes access to app features, data storage, and provider connectivity.

alunacare.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Device + Subscription
ModelHybridBilling cadenceMonthly
Notes

The Aluna device is sold as a one-time hardware purchase. Subscription services are billed separately (monthly or annual). Specific price points are not publicly listed.

alunacare.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Aluna sells an FDA-cleared portable digital spirometer that pairs via Bluetooth with a companion mobile app to measure and track lung function (FEV1%, PEF), symptoms, medications, and environmental factors for asthma and cystic fibrosis patients. The platform extends to a web-based Provider Dashboard for remote patient monitoring with CPT-code billing support, and a Clinical Trials Platform for CROs and academic researchers conducting respiratory studies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Hospital-grade accuracy equivalent to nSpire Koko desktop system
+1 more record
Product overview1 text field

Aluna offers a connected health platform centered on an FDA-cleared portable digital spirometer that connects via Bluetooth to a companion mobile app. The platform includes a provider dashboard for remote patient monitoring and a dedicated clinical trials solution. Together, these products enable patients and healthcare providers to track lung function (FEV1%, PEF), symptoms, medications, and environmental factors; receive AI-powered quality analysis and risk alerts; and share data for telehealth, clinical care, and research purposes. Aluna is part of Huma Therapeutics and was acquired in May 2025.

Product and service4 records
1Aluna Digital Spirometer
CategoryDigital respiratory health hardware
Description

An FDA-cleared portable digital spirometer that measures lung function (FEV1%, PEF) via Bluetooth, featuring hospital-grade accuracy through differential pressure sensor technology, a removable mouthpiece, USB charging, and suitability for both OTC and prescription use by adults and children ages 5+.

2Aluna Companion App
CategoryPatient-facing mobile software
Description

A mobile application that syncs with the Aluna device via Bluetooth to display real-time lung health scores, log symptoms and medications, track environmental factors, gamify daily testing with rewards and challenges, and enable users to share up to 3 months of data with healthcare providers.

3Aluna Provider Dashboard
CategoryClinical software / remote patient monitoring
Description

A web-based clinical portal enabling healthcare providers to remotely monitor patient lung health data, automatically flag at-risk patients, sort tasks by billing code, track time spent per patient, and access flow-volume curves, environmental factors, medication usage, respiratory symptoms, and exercise data for telehealth and reimbursement purposes.

4Aluna Clinical Trials Platform
CategoryClinical research software and services
Description

A clinical research solution providing portable digital spirometry with hospital-grade accuracy, real-time participant data monitoring, algorithmic quality control for spirometry effort, automated flagging of at-risk participants, and an intuitive portal for study management across pediatric and adult populations.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

Huma Therapeutics acquired Aluna in May 2025. Huma is a digital health company specializing in remote patient monitoring and digital health platforms. Aluna operates as part of the Huma Group following the acquisition, with Huma's privacy policy now governing Aluna's data practices. The acquisition reflects intensifying competition among digital health providers.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cohero Health develops connected respiratory devices (spirometers and inhalers) and a SaaS platform for asthma and COPD management. It directly overlaps with Aluna's patient app + provider dashboard model.

TypeBroad incumbent
Description

ResMed is a global leader in sleep and respiratory care, owning Propeller Health. Its MyAir platform and connected CPAP/respiratory devices make it a broad incumbent competitor with overlapping digital-respiratory capabilities.

TypeDirect peer
Description

MIR manufactures portable, connected spirometers (e.g., Spirobank, Smart One) used in clinical, occupational, and home settings, with Bluetooth pairing to mobile apps. It is a direct hardware-and-app competitor to Aluna's spirometer.

4nSpire Health
TypeDirect peer
Description

nSpire Health manufactures the Koko desktop spirometer used as the accuracy benchmark for Aluna. It sells clinical-grade pulmonary function testing systems to hospitals, CROs, and research institutions, competing with Aluna in the clinical-trials and provider segments.

TypeBroad incumbent
Description

Huma Therapeutics is Aluna's parent company following the May 2025 acquisition. It is a broader digital-health / remote-patient-monitoring platform with disease-agnostic modules; its overall platform strategy and RPM distribution directly influence Aluna's go-to-market.

TypeEmerging player
Description

Adherium provides digital respiratory health solutions, including smart inhaler sensors and a connected adherence platform for asthma and COPD. It is an emerging player with partial product overlap with Aluna's connected respiratory approach.

TypeDirect peer
Description

Propeller Health (owned by ResMed) is a digital respiratory health company offering connected inhalers and an adherence platform for asthma and COPD. It competes for the same provider pharma-adherence budgets as Aluna and is the most-recognized brand in connected respiratory.

8NDD Medical Technologies (EasyOne)
TypeDirect peer
Description

NDD Medical Technologies makes the EasyOne line of portable spirometers used in primary care, occupational health, and clinical trials. Its ultrasound-based flow sensor and broad clinical footprint make it a direct competitor in portable spirometry hardware.

TypeDirect peer
Description

NuvoAir is a direct competitor offering a digital respiratory health platform combining a connected home spirometer, app, and clinician dashboard for asthma and COPD management. Its DTC-to-enterprise model, multi-condition scope, and European footprint overlap directly with Aluna's core offering.

TypeDirect peer
Description

Vitalograph is a long-established manufacturer of clinical and home spirometers (e.g., In2itive, lung monitor) used by healthcare professionals, occupational health, and clinical trials. It competes in both consumer home and clinical trial channels.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aluna

Digital Respiratory Health Devicesalunacare.com

Aluna builds an FDA-cleared portable digital spirometer and companion mobile app that enable daily at-home lung function monitoring for asthma and cystic fibrosis patients, serving also healthcare providers and clinical trial sponsors. Acquired by Huma Therapeutics in May 2025.

What Aluna does

Aluna is a digital health company that develops and sells a portable, FDA-cleared digital spirometer and companion mobile application for the daily monitoring of lung function by patients with asthma and cystic fibrosis. Founded in 2016 by Charvi Shetty (CEO) and Inderjit Jutla (CSO) out of UC Berkeley, the company combines a differential pressure sensor with a proprietary machine learning algorithm to deliver hospital-grade accuracy — validated against the nSpire Koko desktop reference system — in a Bluetooth-connected, USB-rechargeable consumer device with a removable mouthpiece. The ML pipeline performs 'adequate effort' quality detection, BTPS environmental corrections using phone-sensor inputs (barometer, accelerometer, internal temperature), and automated at-risk patient flagging. Aluna sells the device direct-to-consumer through alunacare.com (US-only), operates a web-based Provider Dashboard for remote patient monitoring with CPT-code billing workflows, and offers a Clinical Trials Platform for CROs and academic institutions. Revenue is generated through one-time hardware sales and recurring subscription/app services processed via Stripe and Apple App Store. The company was acquired by Huma Therapeutics in May 2025 and now operates as a subsidiary of Huma Therapeutics Inc.

Aluna firmographics

Firmographics
Name
Aluna
Legal name
Huma Therapeutics Inc
Website
https://alunacare.com
Company type
Private
Founded year
2016
Operating status
Acquired
Headcount range
11–50 employees
Short description
Aluna builds an FDA-cleared portable digital spirometer and companion mobile app that enable daily at-home lung function monitoring for asthma and cystic fibrosis patients, serving also healthcare providers and clinical trial sponsors. Acquired by Huma Therapeutics in May 2025.
Ownership category
akta.pro rank

Aluna industry classification

Industry
Product category
Digital Respiratory Health Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAGAH
Pulmonary Function Testing (PFT) & Spirometry Equipment
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHAGAI
Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

  • Digital spirometry device
  • Respiratory health monitoring
  • Remote patient monitoring
  • Lung function tracking
  • Connected health platform

Where Aluna is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Aluna business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Hardware Device Sales: Aluna sells its digital spirometer device directly to consumers and healthcare providers. The device is available for purchase through the website and connects to the companion app via Bluetooth.
  2. Subscription Services: Aluna offers subscription billing for app services. Credit card payment processing is handled through Stripe and Apple App Store. Subscription includes access to app features, data storage, and provider connectivity.

Pricing tiers

ModelBillingPrice
HybridMonthlyDevice + Subscription

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Aluna product offering

Product offering

Core offering

Aluna sells an FDA-cleared portable digital spirometer that pairs via Bluetooth with a companion mobile app to measure and track lung function (FEV1%, PEF), symptoms, medications, and environmental factors for asthma and cystic fibrosis patients. The platform extends to a web-based Provider Dashboard for remote patient monitoring with CPT-code billing support, and a Clinical Trials Platform for CROs and academic researchers conducting respiratory studies.

Product overview

Aluna offers a connected health platform centered on an FDA-cleared portable digital spirometer that connects via Bluetooth to a companion mobile app. The platform includes a provider dashboard for remote patient monitoring and a dedicated clinical trials solution. Together, these products enable patients and healthcare providers to track lung function (FEV1%, PEF), symptoms, medications, and environmental factors; receive AI-powered quality analysis and risk alerts; and share data for telehealth, clinical care, and research purposes. Aluna is part of Huma Therapeutics and was acquired in May 2025.

Differentiator

Problem solved

Functional benefit

Products and services

  • Aluna Digital Spirometer An FDA-cleared portable digital spirometer that measures lung function (FEV1%, PEF) via Bluetooth, featuring hospital-grade accuracy through differential pressure sensor technology, a removable mouthpiece, USB charging, and suitability for both OTC and prescription use by adults and children ages 5+.
  • Aluna Companion App A mobile application that syncs with the Aluna device via Bluetooth to display real-time lung health scores, log symptoms and medications, track environmental factors, gamify daily testing with rewards and challenges, and enable users to share up to 3 months of data with healthcare providers.
  • Aluna Provider Dashboard A web-based clinical portal enabling healthcare providers to remotely monitor patient lung health data, automatically flag at-risk patients, sort tasks by billing code, track time spent per patient, and access flow-volume curves, environmental factors, medication usage, respiratory symptoms, and exercise data for telehealth and reimbursement purposes.
  • Aluna Clinical Trials Platform A clinical research solution providing portable digital spirometry with hospital-grade accuracy, real-time participant data monitoring, algorithmic quality control for spirometry effort, automated flagging of at-risk participants, and an intuitive portal for study management across pediatric and adult populations.

Quantifiable outcome

  • Hospital-grade accuracy equivalent to nSpire Koko desktop system
  • +1 more outcomes

Companies that use Aluna

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Aluna technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Aluna partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Huma TherapeuticscoreStrategic or Co-development Partner · 1 May 2025Huma Therapeutics acquired Aluna in May 2025. Huma is a digital health company specializing in remote patient monitoring and digital health platforms. Aluna operates as part of the Huma Group following the acquisition, with Huma's privacy policy now governing Aluna's data practices. The acquisition reflects intensifying competition among digital health providers.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Aluna competitors and assessment

Company assessment

Direct peers

  • Cohero Health: Cohero Health develops connected respiratory devices (spirometers and inhalers) and a SaaS platform for asthma and COPD management. It directly overlaps with Aluna's patient app + provider dashboard model.
  • MIR (Medical International Research): MIR manufactures portable, connected spirometers (e.g., Spirobank, Smart One) used in clinical, occupational, and home settings, with Bluetooth pairing to mobile apps. It is a direct hardware-and-app competitor to Aluna's spirometer.
  • nSpire Health: nSpire Health manufactures the Koko desktop spirometer used as the accuracy benchmark for Aluna. It sells clinical-grade pulmonary function testing systems to hospitals, CROs, and research institutions, competing with Aluna in the clinical-trials and provider segments.
  • Propeller Health: Propeller Health (owned by ResMed) is a digital respiratory health company offering connected inhalers and an adherence platform for asthma and COPD. It competes for the same provider pharma-adherence budgets as Aluna and is the most-recognized brand in connected respiratory.
  • NDD Medical Technologies (EasyOne): NDD Medical Technologies makes the EasyOne line of portable spirometers used in primary care, occupational health, and clinical trials. Its ultrasound-based flow sensor and broad clinical footprint make it a direct competitor in portable spirometry hardware.
  • NuvoAir: NuvoAir is a direct competitor offering a digital respiratory health platform combining a connected home spirometer, app, and clinician dashboard for asthma and COPD management. Its DTC-to-enterprise model, multi-condition scope, and European footprint overlap directly with Aluna's core offering.
  • Vitalograph: Vitalograph is a long-established manufacturer of clinical and home spirometers (e.g., In2itive, lung monitor) used by healthcare professionals, occupational health, and clinical trials. It competes in both consumer home and clinical trial channels.

Broad incumbents

  • ResMed: ResMed is a global leader in sleep and respiratory care, owning Propeller Health. Its MyAir platform and connected CPAP/respiratory devices make it a broad incumbent competitor with overlapping digital-respiratory capabilities.
  • Huma Therapeutics: Huma Therapeutics is Aluna's parent company following the May 2025 acquisition. It is a broader digital-health / remote-patient-monitoring platform with disease-agnostic modules; its overall platform strategy and RPM distribution directly influence Aluna's go-to-market.

Emerging players

  • Adherium: Adherium provides digital respiratory health solutions, including smart inhaler sensors and a connected adherence platform for asthma and COPD. It is an emerging player with partial product overlap with Aluna's connected respiratory approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Aluna social profiles

Digital presence

Aluna compliance and trust

Trust signal

Compliance4 records

Aluna financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aluna leadership team

Management profile

Number of profiles

Profiles2 records

Aluna funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aluna M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aluna

What does Aluna do?

Aluna sells an FDA-cleared portable digital spirometer that pairs via Bluetooth with a companion mobile app to measure and track lung function (FEV1%, PEF), symptoms, medications, and environmental factors for asthma and cystic fibrosis patients. The platform extends to a web-based Provider Dashboard for remote patient monitoring with CPT-code billing support, and a Clinical Trials Platform for CROs and academic researchers conducting respiratory studies.

Is Aluna a public or private company?

Aluna is a private company. It is classified as corporate owned and is currently acquired.

When was Aluna founded?

Aluna was founded in 2016. It employs 11 to 50 people.

Where is Aluna based?

Aluna is headquartered in San Francisco, United States, in the North America region.

How does Aluna make money?

Two revenue lines are on record. Hardware Device Sales are the primary driver. The others are subscription Services.

Who are Aluna's main competitors?

Direct peers on record are Cohero Health, MIR (Medical International Research), nSpire Health, Propeller Health, NDD Medical Technologies (EasyOne), NuvoAir and Vitalograph. Broad incumbents are ResMed and Huma Therapeutics. Adherium is listed as an emerging player.

Does Aluna have an API?

No public API is recorded for Aluna.

What industry is Aluna in?

Aluna's product category is Digital Respiratory Health Devices. Its primary akta.pro industry code is HLAHAGAH, Pulmonary Function Testing (PFT) & Spirometry Equipment, with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Digital HealthHuma partners with Eckuity Capital and acquires AlunaHuma Therapeutics has acquired remote monitoring company Aluna and partnered with Eckuity Capital to support its mergers and acquisitions strategy. The acquisition adds over 150 US-based health systems to Huma's global footprint, allowing it to expand its reach in respiratory health by integrating Aluna’s solutions into the Huma Cloud Platform.StartupHub.aiHuma Therapeutics Acquires Aluna and Secures Growth Partnership with Eckuity CapitalHuma Therapeutics acquired Aluna, a respiratory health company, and partnered with Eckuity Capital to support its M&A roadmap. Aluna's FDA-cleared respiratory monitoring solutions will be integrated into Huma's platform, upgrading to FDA Class II and supporting over 500,000 patients. The move targets 40+ million U.S. respiratory patients.HIT ConsultantHuma Therapeutics Acquires Aluna, Inks Partnership with Eckuity CapitalHuma Therapeutics acquired Aluna, a respiratory monitoring company, and partnered with Eckuity Capital to expand its digital healthcare offerings. Aluna's peak flow meters will be relaunched on Huma's cloud platform, upgrading to FDA Class II and serving over 500,000 contracted lives. The move strengthens Huma's respiratory health capabilities and supports its M&A strategy.Tech.euUK’s Huma expands US Presence with Aluna acquisition, launches M&A partnership with Eckuity CapitalUK-based healthtech company Huma acquired US respiratory health startup Aluna and established a strategic M&A partnership with Eckuity Capital to accelerate its growth and expand its product ecosystem. This acquisition integrates Aluna’s AI-powered remote monitoring tools into the Huma Cloud Platform, extending Huma's reach to over 150 U.S. health systems serving more than 500,000 lives. The move supports Huma's broader strategy to capitalize on the shift toward decentralized care and digital health infrastructure.HIT ConsultantAluna Raises $15.3M for Lung Health Management PlatformAluna raised $15.3 million in a Series B round to expand its lung health management platform for asthma, cystic fibrosis, and COPD. The AI-enabled spirometer and app have added thousands of patients, with 10x year-over-year growth. The company plans to invest in product and commercial expansion.FinSMEsAluna Raises $15.3M in Series B FundingAluna, a San Francisco-based provider of lung health management platforms, has raised $15.3 million in Series B funding led by Matrix Partners with participation from Rho Ignition and Dr. Warner Carr. The company plans to utilize the capital to expand its product development and commercial efforts, specifically aiming to produce more spirometers and reach new patients. This funding supports Aluna's AI-enabled respiratory management platform designed for asthma, COPD, and cystic fibrosis patients.AxiosExclusive: Aluna inhales $15M Series B for asthma monitoringAluna, a respiratory health management company, raised $15.3 million in Series B capital, according to CEO Charvi Shetty. The funding supports its integrated service that lets patients see how they respond to medications in real time.Business Wire BlogAluna Raises $15.3M in Series B Funding To Empower Asthma, COPD and Cystic Fibrosis Patients and Their DoctorsAluna raised $15.3 million in Series B funding to expand its AI-enabled respiratory management platform for asthma, COPD, and cystic fibrosis patients. The round brings total funding to $27 million, with plans to invest in product and commercial growth. The company aims to leverage lung health data to revolutionize respiratory care.Venture Capital Access OnlineAluna Raises $15.3M in Series B Funding To Empower Asthma, COPD and Cystic Fibrosis Patients and Their DoctorsAluna announced the completion of a $15.3 million Series B funding round led by Matrix Partners to expand its AI-enabled respiratory management platform for asthma, COPD, and cystic fibrosis patients. The company reported a 10x year-over-year growth in its patient base and plans to use the capital to increase production of its FDA-cleared spirometer devices and enhance its commercial offerings.